정책동향
A comparative analysis of the role and impact of Health Technology Assessment
- 등록일2011-07-19
- 조회수4707
- 분류정책동향 > 기타 > 기타
-
자료발간일
2011-05-13
-
출처
Charles River Associates
-
원문링크
-
키워드
#Health Technology
- 첨부파일
HTA_Comparison_Report.PDF
A comparative analysis of the role and impact of
Health Technology Assessment
EXECUTIVE SUMMARY
Over the last ten years, Health Technology Assessment (HTA) has become an increasingly important part of the assessment system for new medicines. It is generally agreed that HTA has the potential to assist payers in making informed decisions about allocating resources (including expenditure on medicines) in the health system. However, it is also possible that a poorly designed or managed HTA process runs the risk of denying patients appropriate access to medical technologies, inefficiently allocating resources, constraining clinical freedom and sending distorted signals to medical technology providers.
To this end a considerable amount of effort has been put into developing best practice principles which demonstrate a degree of consensus between academia, payers and industry. Charles River Associates (“CRA”) was asked by EFPIA, PhRMA, Medicines Australia and EuropaBio to undertake a comparative assessment of the role and impact of Health Technology Assessment (HTA) in different parts of the world. In this report, we use these principles to compare how different systems use HTA, the basis of the approach they apply, how it works in practice and the consequences for the key stakeholders.
....(계속)
☞ 자세한 내용은 첨부파일을 참고하시기 바랍니다.